Luqi Huang - Covid-19 From Traditional Chinese Medicine Perspective: Severe Clinical Cases In The Context Of Syndrome Differentiation

Published by

World Scientific Publishing Co. Pte. Ltd.

5 Toh Tuck Link, Singapore 596224

USA office: 27 Warren Street, Suite 401-402, Hackensack, NJ 07601

UK office: 57 Shelton Street, Covent Garden, London WC2H 9HE

Library of Congress Control Number: 2020950190

British Library Cataloguing-in-Publication Data

A catalogue record for this book is available from the British Library.

:

Originally published in Chinese by Shanghai Scientific & Technical Publishers

Copyright 2020 by Shanghai Scientific & Technical Publishers

English translation rights arranged with Shanghai Scientific & Technical Publishers

COVID-19 FROM TRADITIONAL CHINESE MEDICINE PERSPECTIVE

Severe Clinical Cases in the Context of Syndrome Differentiation

Copyright 2021 by World Scientific Publishing Co. Pte. Ltd.

All rights reserved. This book, or parts thereof, may not be reproduced in any form or by any means, electronic or mechanical, including photocopying, recording or any information storage and retrieval system now known or to be invented, without written permission from the publisher.

For photocopying of material in this volume, please pay a copying fee through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA. In this case permission to photocopy is not required from the publisher.

ISBN 978-981-122-874-2 (hardcover)

ISBN 978-981-122-875-9 (ebook for institutions)

ISBN 978-981-122-876-6 (ebook for individuals)

For any available supplementary material, please visit

https://www.worldscientific.com/worldscibooks/10.1142/12056#t=suppl

Typeset by Stallion Press

Email:

Printed in Singapore

With white clothes and armor, national doctors of traditional Chinese medicine (TCM) took the lead. In late January 2020, the outbreak of COVID-19 in Wuhan had concerned millions of people across the country. Under the unified leadership of the Central Committee of the Communist Party of China (CCCPC) and the State Council, and the State Administration of TCMs unified deployment, China Academy of Chinese Medical Sciences (CACMS) quickly established the first batch of the national TCM medical teams consisting of 35 people from Xiyuan Hospital and Guanganmen Hospital, and led by Academician Luqi Huang, president of CACMS. On January 25th, the first day of the Lunar New Year, the medical team rushed to Wuhan and completely took over the No. 1 south ward of Wuhan Jinyintan Hospital.

All of patients in the No. 1 south ward were severe or critical cases of COVID-19. In the absence of any effective antiviral drug or vaccine from western medicine, Academician Luqi Huang proposed to highlight the advantages of TCM on COVID-19 treatment by starting the treatment at an earlier stage and fully participating and getting involved deeply during the whole treatment process, in order to bring TCM into full play for the prevention and control of COVID-19.

During the following 66 days, the first batch of the national TCM medical team demonstrated in practice the responsibility that a national team should take and, fulfilled the historical mission, for the country, for the people, and showed the spirit of dedication of an eminent and sincere doctor. With hard work, the prevention and control of COVID-19 was achieved in a phased manner, which contributed the China Method and China Experience to people around the world for the prevention and treatment of COVID-19.

First of all, multiple methods were developed simultaneously, where scientific and clinical research promoted each other reciprocally. Treating, researching and summarizing at the same time was the working principle that was strictly adhered to by the national TCM medical team. The TCM medical team always attached equal importance to clinical, nursing, and scientific research, along with coordination and cooperation among the frontline and back-end teams. The clinical and basic research promoted and complemented each other, leading to a series of new concepts, new techniques, and new methods, which made outstanding contributions to the prevention and control of COVID-19.

Second, the deployment was made scientifically, where the TCM treatment plan set the benchmark. Scientific analysis, precise treatment was the decision-making principle of the national TCM medical team. According to the characteristics of the disease, the medical team made scientific policies and conducted classified treatments. Aiming at different stages of prevention, treatment, and rehabilitation, the medical team formulated a set of mature and effective treatments for COVID-19, based on four main characteristics: treating at an earlier stage, participating in the whole process, classifying the case as per the respective methods, and laying equal emphasis on both TCM and western medicine. Moreover, based on the clinical data, the treatment plan was continually optimized according to the clinical characteristics of the disease, which fully demonstrated the characteristics and advantages of TCM in COVID-19 treatment.

Third, new drugs were under research and development, where effectiveness was shown following the principle eliminating dampness and dispelling toxin. Dispel the evil Qi and strengthen the healthy Qi, eliminate dampness and dispel toxin was the principle and method of treatment that the national TCM medical team summarized from clinical practice. At the early stage of clinical treatment, Academician Luqi Huang asked the back-end team to prepare for new drug research and development, so that it could be started once the effective prescription was determined. With the gradual understanding of COVID-19, the national TCM medical team continually optimized the treatment plan according to the clinical characteristic of the disease, and finally established the treatment principle, dispelling the evil Qi and strengthening the healthy Qi, and the basic treatment method, eliminating dampness and dispelling toxin. Under the guidance of the principle and the basic treatment method, the core formula for COVID-19, Huashi Baidu formula, was created and a new drug for COVID-19, Huashi Baidu granules, was developed. Huashi Baidu granules are a materialized carrier reflecting the clinical efficacy of TCM against COVID-19, and also the first new TCM drugs on COVID-19 to be completely patented nationwide.

Last but not least, both TCM and western medicine were given equal importance, where the cooperation of two systems made new achievements. The integration of TCM and the western medicine, the equal emphasis on TCM and the western medicine, and the combining usage of TCM and the western medicine in prescription were the diagnosis and treatment principles of the national TCM medical team for the severe and critical COVID-19 cases. Academician Luqi Huang believed that TCM should be further strengthened for severe and critical COVID-19 patients, and strongly advocated TCM injections on the basis of oral application of TCM. He also stressed many times that patients without indications for antibiotics or steroids should be treated with TCM, while the application of western medicine should not be excluded. When it was necessary, the integration of TCM and western medicine was done, with equal emphasis on both, and the combined usage of TCM and western medicine in prescription was accomplished, so that both TCM and western medicine could demonstrate their advantages, complement each other, and cooperate with each other to form a China Plan for prevention and treatment of COVID-19.